Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

COSTEM 2019 | Transplantation in an evolving therapy landscape

Peter Bader • 26 Oct 2019
COSTEM 2019
Acute Lymphoblastic Leukemia CAR-T

Peter Bader, MD, PhD, Goethe University Frankfurt, Frankfurt, Germany, discusses transplantation in an evolving therapy landscape and how to place CAR-T in the r/r pediatric acute lymphoblastic leukemia (pedALL) treatment algorithm at the 5th International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) 2019, held in Berlin, Germany.

More from Peter Bader

3:07
How will CAR-T cells help us cure Ph+ ALL?
Peter Bader • 25 Oct 2019
2:14
Mesenchymal stromal cells in the treatment of acute GVHD
Peter Bader • 25 Oct 2019
4:13
Prof. Bader’s highlights from EBMT 2019
Peter Bader • 10 Apr 2019
0:57
The aims of the EBMT Paediatric Disease Working Party
Peter Bader • 9 Sep 2016

Related Videos

2:06
Managing relapsed ALL: the role of novel cellular therapies & importance of conditioning regimens
Christina Peters • 15 Apr 2024
1:48
Do all patients require maintenance therapy following alloSCT?
Mark Levis • 16 Apr 2024
1:15
Comparing the efficacy of salvage therapies in adult B-ALL: a retrospective real-world study
Alex Rampotas • 16 Apr 2024
3:34
Total marrow and lymphoid irradiation plus cyclophosphamide & etoposide in poor-risk acute leukemias
Anthony Stein • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals